Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 630

1.
2.

Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients.

Monti JM, Attali P, Monti D, Zipfel A, de la Giclais B, Morselli PL.

Pharmacopsychiatry. 1994 Jul;27(4):166-75.

PMID:
7972349
3.
5.

A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects.

Voderholzer U, Riemann D, Hornyak M, Backhaus J, Feige B, Berger M, Hohagen F.

Eur Arch Psychiatry Clin Neurosci. 2001 Jun;251(3):117-23.

PMID:
11697572
6.

A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.

Scharf MB, Roth T, Vogel GW, Walsh JK.

J Clin Psychiatry. 1994 May;55(5):192-9.

PMID:
8071269
7.

Zolpidem for persistent insomnia in SSRI-treated depressed patients.

Asnis GM, Chakraburtty A, DuBoff EA, Krystal A, Londborg PD, Rosenberg R, Roth-Schechter B, Scharf MB, Walsh JK.

J Clin Psychiatry. 1999 Oct;60(10):668-76.

PMID:
10549683
8.

Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.

Roth T, Soubrane C, Titeux L, Walsh JK; Zoladult Study Group.

Sleep Med. 2006 Aug;7(5):397-406. Epub 2006 Jul 3.

PMID:
16815744
9.
10.

Minimal rebound insomnia after treatment with 10-mg zolpidem.

Ware JC, Walsh JK, Scharf MB, Roehrs T, Roth T, Vogel GW.

Clin Neuropharmacol. 1997 Apr;20(2):116-25.

PMID:
9099463
11.

[Treatment of insomnia related to depressive disorders. Effects of zolpidem versus flunitrazepam administration and withdrawal evaluated in a double-blind study].

Guazzelli M, Ciapparelli A, Balsamo EL, Gemignani A, Sarteschi P.

Minerva Psichiatr. 1993 Sep;34(3):193-203. Italian.

PMID:
8302193
12.

Evaluation of zolpidem, triazolam, and placebo as hypnotic drugs the night before surgery.

Morgan PJ, Chapados R, Chung FF, Gauthier M, Knox JW, Le Lorier J.

J Clin Anesth. 1997 Mar;9(2):97-102.

PMID:
9075032
13.

Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder.

Fava M, Asnis GM, Shrivastava R, Lydiard B, Bastani B, Sheehan D, Roth T.

J Clin Psychopharmacol. 2009 Jun;29(3):222-30. doi: 10.1097/JCP.0b013e3181a390ba.

PMID:
19440075
14.

Eight weeks of non-nightly use of zolpidem for primary insomnia.

Walsh JK, Roth T, Randazzo A, Erman M, Jamieson A, Scharf M, Schweitzer PK, Ware JC.

Sleep. 2000 Dec 15;23(8):1087-96.

PMID:
11145323
15.
16.

A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients.

Hajak G, Hedner J, Eglin M, Loft H, Stórustovu SI, Lütolf S, Lundahl J; Gaboxadol Study 99775 Group.

Sleep Med. 2009 Aug;10(7):705-12. doi: 10.1016/j.sleep.2008.09.010. Epub 2009 Apr 5.

PMID:
19346160
17.

[Contribution of zolpidem in the management of sleep disorders].

Lavoisy J, Zivkovic B, Benavides J, Perrault GH, Robert P.

Encephale. 1992 Jul-Aug;18(4):379-92. French.

PMID:
1363657
18.

Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.

Fava M, Asnis GM, Shrivastava RK, Lydiard B, Bastani B, Sheehan DV, Roth T.

J Clin Psychiatry. 2011 Jul;72(7):914-28. doi: 10.4088/JCP.09m05571gry. Epub 2010 Dec 28.

PMID:
21208597
19.

Effects of zolpidem on cyclic alternating pattern, an objective marker of sleep instability, in Japanese patients with psychophysiological insomnia: a randomized crossover comparative study with placebo.

Ozone M, Yagi T, Itoh H, Tamura Y, Inoue Y, Uchimura N, Sasaki M, Shimizu T, Terzano MG, Parrino L.

Pharmacopsychiatry. 2008 May;41(3):106-14. doi: 10.1055/s-2008-1058104.

PMID:
18484552
20.

Rebound insomnia after hypnotic withdrawal in insomniac outpatients.

Hajak G, Clarenbach P, Fischer W, Rodenbeck A, Bandelow B, Broocks A, Rüther E.

Eur Arch Psychiatry Clin Neurosci. 1998;248(3):148-56.

PMID:
9728734

Supplemental Content

Support Center